Cancer of Mouth clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
open to eligible people ages 18 years and up
This study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
La Jolla, California
Our lead scientists for Cancer of Mouth research studies include Joseph Califano.
Last updated: